Answer Summary

Members shared their experiences with the ForeseeHome monitor for tracking macular degeneration, with most paying around $77 monthly... Read more

Members shared their experiences with the ForeseeHome monitor for tracking macular degeneration, with most paying around $77 monthly out-of-pocket even with insurance like Blue Cross, Medicare, and Cigna. Several members explained that while the device doesn't prevent AMD from worsening, it provides crucial early detection by monitoring vision changes in real time and alerting both patients and doctors if dry AMD converts to wet, which allows for emergency intervention when time is most critical. A recurring theme was that many members view the monitor as far superior to traditional Amsler grids and worth the cost to preserve their sight, with one member successfully using it for eight years.